Insperity posts $20 million Q3 net loss as revenue rises 4%; UnitedHealthcare deal extended to 2028
Insperity reported third-quarter 2025 revenue up 4% to $1.6 billion, but a net loss of $20 million, or $(0.53) per diluted share, compared with net income of $3 million a year earlier, as gross profit fell 15% on higher-than-expected benefits costs. The company also amended its UnitedHealthcare medical coverage arrangement, extending it through 2028 with additional cost savings starting in 2026, and gave its full-year 2025 adjusted EPS guidance of $0.84 to $1.47.
Key points
- Q3 2025 revenue rose 4% to $1.6 billion; gross profit fell 15% to $195 million
- Q3 2025 net loss of $20 million; diluted EPS $(0.53) versus $0.07 in Q3 2024; adjusted EPS $(0.20)
- UnitedHealthcare amendment extends the arrangement through 2028 and lets Insperity elect a claim cost limit of $500,000, $750,000, or $1,000,000 per participant per year
- Q4 2025 adjusted EPS guidance is $(0.79) to $(0.16); full-year 2025 adjusted EPS guidance is $0.84 to $1.47
The filing
Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.